TABLE 2.
Knowledge of participants about COVID‐19
| Knowledge about COVID−19 (n = 1,216) | Distribution n (%) |
|---|---|
| COVID−19 spreads by? | |
| Droplets from the nose or mouth of infected person | 1,001 (82.3) |
| Touching infected surfaces | 841 (69.2) |
| Touching infected objects | 829 (68.2) |
| Incubation period for the COVID−19 last? | |
| less than 4 days | 30 (2.5) |
| less than 7 days | 33 (2.7) |
| up to 14 days | 1,153 (94.8) |
| Cause of the COVID−19 is a | |
| Virus | 1,208 (99.3) |
| Bacterium | 3 (0.2) |
| Parasite | 2 (0.0) |
| Main clinical symptoms of the COVID−19 include | Yes | No |
|---|---|---|
| Fever | 1,187 (97.6) | 29 (2.4) |
| Dry cough | 1,025 (84.3) | 191 (15.7) |
| Dyspnoea | 998 (82.0) | 218 (18.0) |
| Sore throat | 654 (53.7) | 562 (46.3) |
| Muscle aches | 531 (43.6) | 685 (56.4) |
| Shortness of breath | 484 (39.8) | 732 (60.2) |
| Headache | 426 (35.0) | 790 (65.0) |
| Fatigue | 911 (74.9) | 305 (25.1) |
| Vomiting | 365 (30.0) | 851 (70.0) |
| Pharyngitis | 177 (14.5) | 1,039 (85.5) |
| Rhinorrhoea | 120 (9.9) | 1,096 (90.1) |
| Chest pain | 583 (47.3) | 633 (52.7) |
| Diarrhoea | 561 (45.5) | 655 (54.5) |
| Nausea | 190 (15.6) | 1,026 (84.4) |
| Groups with higher risk of developing a severe COVID−19 | ||
| Elderly people | 1,012 (83.2) | 204 (16.8) |
| People with chronic disease (e.g. chronic obstructive pulmonary disease) | 1,094 (90.0) | 122 (10.0) |
| Obese people | 249 (20.5) | 967 (79.5) |
| Is there a vaccine, drug or treatment for COVID−19? | ||
| Vaccine | 77 (6.3) | 1,139 (93.7) |
| Specific treatment | 160 (12.3) | 1,056 (87.7) |
| Supportive care | 628 (51.6) | 588 (48.4) |